Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNß-1b trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNß-1b trial.
Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNß-1b trial. Neurology. 2012 Apr 24; 78(17):1315-22.
View in:
PubMed
subject areas
Adjuvants, Immunologic
Adult
Age of Onset
Cause of Death
Female
Humans
Interferon beta-1b
Interferon-beta
Kaplan-Meier Estimate
Male
Multiple Sclerosis, Relapsing-Remitting
Survival Analysis
authors with profiles
Anthony T. Reder